Medical

Asthma Inhaler Costs to Be Slashed as Drugmakers Introduce $35 Price Cap

Asthma Inhaler Costs to Be Slashed as Drugmakers Introduce $35 Price Cap

Many Americans will benefit from reduced inhaler costs as AstraZeneca and Boehringer Ingelheim implement new out-of-pocket price caps of $35 per month, reflecting a move towards more affordable asthma medication following years of public concern over high prices.


Health Insurer Shares Plunge After UnitedHealth Warns of Medicaid 'Disturbance'

Shares of major health insurers fell sharply after UnitedHealth Group executives warned of a "disturbance" in its Medicaid business and discussed patient healthcare utilization at an investor conference.

Telehealth Startup Ro Develops Online Tracker to Combat Wegovy Shortages Amid Weight-Loss Drug Demand

Telehealth startup Ro has launched a free online tracker to help patients and doctors locate in-stock weight-loss drugs like Wegovy amid national shortages, providing real-time availability and the option to report outages to the FDA.

Elon Musk’s Neuralink Reportedly Plans to Recruit 3 Participants for Long-Term Study

Elon Musk's brain-chip company Neuralink aims to test the implant on three people over several years.


Latest News

Pfizer Unveils Multi-Year Cost-Cutting Plan to Offset Plummeting COVID-19 Vaccine Sales
Pfizer has announced a multi-year cost-cutting program focusing on operational efficiencies, network structure changes, and product portfolio enhancements, aiming to save $1.5 billion by 2027 amidst declining COVID-19 vaccine sales.
Louisiana To Categorize Abortion Pills as Dangerous Controlled Substances—What To Know About New Bill
Louisiana is now aiming to categorize some abortion pills as dangerous controlled substances. The House has already passed the new bill.
Nestle to Launch Weight Management Food Products Targeting Ozempic, Wegovy Users in Q4 2024
Nestle announced that they would be launching its ‘Vital Pursuit’ food line by Q4 2024, which would target those using the semaglutide drugs Ozempic and Wegovy.
Whistleblower Claims GlaxoSmithKline Lies to FDA, Federal Government About Zantac Safety Claims
A whistleblower has come out with allegations that GlaxoSmithKline (GSK) deceived the public about the safety of Zantac, a popular heartburn medicine.
FDA Gives Green Light to Amgen's Drug for Small Cell Lung Cancer Treatment
Amgen's treatment for patients with the most deadly form of lung cancer has been approved by the Food and Drug Administration on Thursday.
J&J, AstraZeneca COVID-19 Vaccines Uncover Autoimmune Link to Rare Blood Clots, Paving Way for Future Vaccine Strategies
Researchers have discovered an autoimmune reaction in rare, fatal blood clots tied to Johnson & Johnson and AstraZeneca COVID-19 vaccines.
Obesity Drug Wegovy Reduces Risk of Heart Attack, Stroke, Despite Not Contributing Much to Patient’s Weight Loss, Study Finds
Researchers have discovered that anti-obesity injections may significantly decrease the likelihood of heart attacks, strokes, or heart failure in individuals who are obese, regardless of the amount of weight they shed while taking the medication.
Pfizer Agrees to Settle Over 10,000 That Heartburn Drug Zantac Causes Cancer
Pfizer has agreed to settle over 10,000 lawsuits concerning the alleged connection between its product, Zantac, and cancer.
US Allegedly Reclassifying Marijuana as Less Dangerous Drug! Here's What To Know About DEA's Proposal
The Biden Administration could make a historic drug policy shift. The US government is allegedly reclassifying marijuana as a less dangerous drug. If this happens, the Biden Administration would be making a history shift in the nation's drug policy.
COVID-19 Vaccines Not Linked to Sudden Deaths of Young People, CDC Study Reveals
A recent study conducted by the Centers for Disease Control and Prevention (CDC) has revealed that there is no link between COVID-19 vaccines and cardiac death in younger adults.
  1 2 3 4 5 6 7 8 9 10  
Real Time Analytics